Policy Notices

• NIH Application Instruction Updates Data Management and Sharing (DMS) Costs
  (NOT-OD-23-161)
  National Institutes of Health
  

General Notices

• Notice of Participation of the National Institute on Aging (NIA) in PAR-23-219, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)"
  (NOT-AG-23-047)
  National Institute on Aging
  

• Notice of Participation of the National Institute on Aging (NIA) in PAR-23-220, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)"
  (NOT-AG-23-048)
  National Institute on Aging
  

• Notice of NCIs Participation in RFA-OD-23-018 ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed)
  (NOT-CA-23-082)
  National Cancer Institute
  

• Notice of Research Opportunity Announcements for the HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW): Addressing Overdose, Substance Use, Mental Health, and Pain Program
  (NOT-DA-23-030)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  

• NIDCR Notice of Participation in PAR-23-109, NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
  (NOT-DE-23-014)
  National Institute of Dental and Craniofacial Research
  

Notice of Changes to Funding Opportunities

• Notice to Update Part 2, Sections I, III, and IV - Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Acute Low Back Pain (U01) Clinical Trials Not Allowed
  (NOT-FD-23-012)
  Food and Drug Administration
  

• Notice to Update Part 2, Sections I, III, and IV - Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Laparoscopic Abdominal Surgeries (U01) Clinical Trials Not Allowed
  (NOT-FD-23-013)
  Food and Drug Administration
  

• Notice of Change to Extend Last Receipt Date for NINDS Innovation Grants to Nurture Initial Translational Efforts (IGNITE) PAR-21-122, PAR-21-123 and PAR-21-124 (R61/R33 Clinical Trial Not Allowed)
  (NOT-NS-23-095)
  National Institute of Neurological Disorders and Stroke
  

• Notice of NINDS Participation in PAR-23-109 "NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)"
  (NOT-NS-23-102)
  National Institute of Neurological Disorders and Stroke
  National Institute of Allergy and Infectious Diseases
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for High-Priority Behavioral and Social Research Networks??(R24 Clinical Trial Optional)
  (NOT-AG-23-044)
  National Institute on Aging
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
  (NOT-DC-23-015)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
  (NOT-DC-23-016)
  National Institute on Deafness and Other Communication Disorders
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplement for Accelerating Research in Understudied Skin Types
  (NOT-AR-24-008)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Special Interest (NOSI): Accelerating Research in Understudied Skin Types
  (NOT-AR-24-009)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Special Interest (NOSI): Supporting Recovery-Oriented, Family-Centered Care for Pregnant, Postpartum, and Parenting Women with Opioid Use Disorder
  (NOT-DA-24-008)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): HEAL Initiative: Leveraging Inpatient Medical or Surgical Hospitalizations to Improve Outcomes for People Who Use Drugs
  (NOT-DA-24-011)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Role of social function on SUD treatment and outcomes
  (NOT-DA-25-026)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Maternal Health and the Dental, Oral, and Craniofacial Development of their Children
  (NOT-DE-23-005)
  National Institute of Dental and Craniofacial Research
  

Funding Opportunities

• Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
  (PAR-23-240)
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Application Receipt Date(s): May 25, 2026
  
  

• Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
  (PAR-23-248)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): September 26, 2025
  
  

• Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  (PAR-23-254)
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): September 07, 2026
  
  

• Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
  (PAR-23-255)
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): September 07, 2026
  
  

• Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
  (RFA-DA-25-001)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 14, 2024
  
  

• Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
  (RFA-DA-25-002)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 14, 2024
  
  

• A Consortium for Gut-Brain Communication in Parkinsons Disease (U01 Clinical Trial Not Allowed)
  (RFA-DK-22-036)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): November 15, 2023
  
  

• A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed)
  (RFA-DK-23-001)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): November 15, 2023
  
  

• Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
  (RFA-HD-24-009)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  John E. Fogarty International Center
  Application Receipt Date(s): December 06, 2023
  
  

• Network of Genomics-Enabled Learning Health Systems (gLHS) Clinical Sites (U01 Clinical Trial Required)
  (RFA-HG-23-041)
  National Human Genome Research Institute
  Application Receipt Date(s): November 07, 2023
  
  

• Network of Genomics-Enabled Learning Health Systems (gLHS) Coordinating Center (U01 Clinical Trials Required)
  (RFA-HG-23-042)
  National Human Genome Research Institute
  Application Receipt Date(s): November 07, 2023
  
  

• Validating digital health technologies for monitoring biomarkers in ADRD clinical trials (R61/R33 - Clinical Trials Optional)
  (RFA-NS-24-026)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 17, 2023
  
  

• Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)
  (RFA-OD-23-021)
  Office of Disease Prevention
  National Cancer Institute
  Application Receipt Date(s): December 06, 2023